MISSION Therapeutics

0 followers


MISSION Therapeutics offers a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes (DUBs).

Industries

+2

Headquarters

Stage

Employees

Links

Anker Lundemose

Collapse
Suhail Nurbhai
Chief Medical Officer
Nick Edmunds
Chief Technology Officer
Paul Thompson
Chief Scientific Officer
Paul Wallace
Chief Business Officer
Charlotte Knights
Director Of Translational Biomarkers
Kevin Wood
Head of IT
Pau Aceves, MPharm, MSc
Head of Clinical Pharmacology & Pharmacometrics
Sarah Almond
VP Pharmacology